Research Analysts’ Updated EPS Estimates for December, 1st (ASV, AXSM, BSGM, CDW, CHEK, DSG, FBR, FIVE, FNV, HM-B)

Research Analysts’ updated eps estimates for Friday, December 1st:

ASV (NASDAQ:ASV) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “ASV Holdings Inc. is a designer and manufacturer of compact construction equipment which consists of loader and skid steer loader equipment. It operates primarily in North America, Australia and New Zealand. ASV Holdings Inc. is based in Grand Rapids, United States. “

Axsome Therapeutics (NASDAQ:AXSM) was given a $13.00 price target by analysts at Cantor Fitzgerald. The firm currently has a buy rating on the stock.

Biosig Technologies (OTCMKTS:BSGM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.50 price target on the stock. According to Zacks, “BioSig Technologies, Inc. is a medical device company which is engaged in developing technology platform to improve cardiac recording during electrophysiology studies and ablation procedures. “

CDW (NASDAQ:CDW) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “CDW Corporation offers information technology products and services to business, government, education and healthcare customers primarily in the United States and Canada. Its hardware products comprise network communications, notebooks/mobile devices, data storage, video monitors, printers, desktops and servers as well as NetComm products. The company’s software services include licensing, licensing management, software solutions and services. In addition, it offers configuration services which include virtualization, collaboration, security, mobility, data centre optimization and cloud computing. CDW Corporation is headquartered in Vernon Hills, Illinois. “

Check-Cap (NASDAQ:CHEK) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Check Cap Ltd. is a medical diagnostics company. The company is engaged in the development of an ingestible imaging capsule for the screening of colorectal cancer. Check Cap Ltd. is based in Mount Carmel, Israel. “

Descartes Systems Group (TSE:DSG) (NASDAQ:DSGX) had its target price raised by Barclays PLC from C$39.00 to C$42.00.

Fibria Celulose (NYSE:FBR) had its neutral rating reissued by analysts at Credit Suisse Group AG.

Five Below (NASDAQ:FIVE) had its target price increased by UBS AG from $52.00 to $64.00. The firm currently has a neutral rating on the stock.

Five Below (NASDAQ:FIVE) had its price target increased by Buckingham Research from $62.00 to $75.00. Buckingham Research currently has a buy rating on the stock.

Franco Nevada (NYSE:FNV) (TSE:FNV) had its target price cut by TD Securities from $97.00 to $96.00. The firm currently has a buy rating on the stock.

H & M Hennes & Mauritz (STO:HM-B) was given a SEK 177 price target by analysts at Goldman Sachs Group Inc. The firm currently has a sell rating on the stock.

Vmware (NYSE:VMW) had its price target raised by CIBC from $120.00 to $135.00. CIBC currently has an outperform rating on the stock.

Receive News & Ratings for ASV Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ASV Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply